Company Profile
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS to increase product lifecycle with industrial AI. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
Latest News
Thai vehicle sales rise 17% in June
EQT raises Perpetual bid to about A$2.6bn
If I Only Had $500 to Invest, This Is the ETF I'd Buy Right Now
Back-to-School 2026: In-Store Shopping Dominates as Canadian Parents Navigate $4.5 Billion Season
Form 8.3 - Amendment
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.siemens-healthineers.com |
| Audit Risk | 1 |
| Board Risk | 7 |
| Overall Risk | 3 |
| Market Cap | 39.68B |
| Trailing P/E | 19.06 |
| Forward P/E | 14.39 |
| Dividend Rate | 1 |
| Dividend Yield | 2.85% |
| Trailing Annual Div. Rate | 1 |
| Trailing Annual Div. Yield | 2.85% |
| Trailing EPS | 1.86 |
| Forward EPS | 2.46 |
| Book Value | 16.2 |
| Price-to-Book | 2.19 |
| Enterprise-to-Revenue | 2.29 |
| Enterprise-to-EBITDA | 13.5 |
| Ex-Dividend Date | 02/06/2026 |
| Earnings Date | 07/31/2026 |
| Earnings Call Date | 07/31/2026 |
| Earnings Average | 0.53 |
| Earnings Low | 0.51 |
| Earnings High | 0.54 |
| Revenue Average | 5.65B |
| Revenue Low | 4.73B |
| Revenue High | 5.83B |